$40.11
0.972.48%
At Close: -
$40.11
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Apellis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Apellis Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.28 | $-0.32 | 12.5 % |
Mar 2024 | 2024-05-07 | $-0.54 | $-0.52 | -3.85 % |
Dec 2023 | 2024-02-27 | $-0.73 | $-0.69 | -5.80 % |
Sep 2023 | 2023-11-01 | $-1.17 | $-0.85 | -37.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $199.69M | $193.78M | 3.05 % |
Mar 2024 | 2024-05-07 | $172.33M | $163.35M | 5.49 % |
Dec 2023 | 2024-02-27 | $146.38M | $143.59M | 1.94 % |
Sep 2023 | 2023-11-01 | $110.40M | $99.74M | 10.7 % |
Apellis Pharmaceuticals (APLS) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.28, which beat the estimate of $-0.32.
The Actual Revenue was $199.7M, which beat the estimate of $193.8M.
Browse earnings estimates, EPS, and revenue on all stocks.